CFTR founder mutation causes protein trafficking defects in Chinese patients with cystic fibrosis

Cystic fibrosis (CF) is a rare condition in Asians. Since 1985, only about 30 Chinese patients have been reported with molecular confirmation.

[1]  X. Tian,et al.  p.G970D is the most frequent CFTR mutation in Chinese patients with cystic fibrosis , 2016, Human Genome Variation.

[2]  Adam Kiezun,et al.  Exome Aggregation Consortium , 2016 .

[3]  I. Sabirzhanova,et al.  Rescue of NBD2 Mutants N1303K and S1235R of CFTR by Small-Molecule Correctors and Transcomplementation , 2015, PloS one.

[4]  X. Tian,et al.  Characterization of gene mutations and phenotypes of cystic fibrosis in Chinese patients , 2015, Respirology.

[5]  Nikhil T. Awatade,et al.  Measurements of Functional Responses in Human Primary Lung Cells as a Basis for Personalized Therapy for Cystic Fibrosis , 2014, EBioMedicine.

[6]  S. Shyur,et al.  Cystic fibrosis: experience in one institution. , 2014, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[7]  A. Salas,et al.  Multiple Local and Recent Founder Effects of TGM1 in Spanish Families , 2012, PloS one.

[8]  V. Raia,et al.  An overview of international literature from cystic fibrosis registries. Part 3. Disease incidence, genotype/phenotype correlation, microbiology, pregnancy, clinical complications, lung transplantation, and miscellanea. , 2011, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[9]  P. Sham,et al.  Genome-Wide Association Study in Asian Populations Identifies Variants in ETS1 and WDFY4 Associated with Systemic Lupus Erythematosus , 2010, PLoS genetics.

[10]  D. Sheppard,et al.  Direct Sensing of Intracellular pH by the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Cl− Channel*♦ , 2009, The Journal of Biological Chemistry.

[11]  O. Moran,et al.  On the measurement of the functional properties of the CFTR. , 2008, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[12]  B. Kerem,et al.  Consensus on the Use and Interpretation of Cystic Fibrosis Mutation Analysis in Clinical Practice , 2022 .

[13]  M. Welsh,et al.  Processing and function of CFTR-ΔF508 are species-dependent , 2007, Proceedings of the National Academy of Sciences.

[14]  C. Niu,et al.  Novel Mutation (I1023R) in Two Taiwanese Siblings of Cystic Fibrosis , 2007 .

[15]  C. Castellani,et al.  A survey of newborn screening for cystic fibrosis in Europe. , 2007, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[16]  M. Welsh,et al.  Processing and function of CFTR-DeltaF508 are species-dependent. , 2007, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Victoria M. Pratt,et al.  Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel , 2004, Genetics in Medicine.

[18]  M. Amaral,et al.  Unusually common cystic fibrosis mutation in Portugal encodes a misprocessed protein. , 2003, Biochemical and biophysical research communications.

[19]  L. Wong,et al.  Two novel null mutations in a Taiwanese cystic fibrosis patient and a survey of East Asian CFTR mutations , 2003, American journal of medical genetics. Part A.

[20]  J. Wine,et al.  Two novel mutations in a cystic fibrosis patient of Chinese origin , 1999, Human Genetics.

[21]  Y. Yamashiro,et al.  The estimated incidence of cystic fibrosis in Japan. , 1997, Journal of pediatric gastroenterology and nutrition.

[22]  L. Tsui,et al.  Skipping of exon 12 as a consequence of a point mutation (1898 + 5G → T) in the cystic fibrosis transmembrane conductance regulator gene found in a consanguineous Chinese family , 1995, Clinical genetics.

[23]  M. Welsh,et al.  Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis , 1993, Cell.

[24]  L. Tsui,et al.  The spectrum of cystic fibrosis mutations. , 1992, Trends in genetics : TIG.